The presence of hereditary low-risk thrombophilia (such as heterozygosity for FVL or prothrombin G20210A mutation) seems to have a greater effect than acquired thrombophilia or other dispositional risk factors on procoagulant activity in pregnancy. This evidence concerns the gene F2 and Rare hereditary thrombophilia.